The duration of GLP-1 weight loss treatment varies by patient due to health profile, metabolism, desired weight loss goals, adherence to related diet and exercise plans, and the potential need to manage weight-related comorbidities
Aging leads to a loss of CYP19, a key enzyme in estrogen synthesis, resulting in the upregulation of pro-apoptotic genes such as p53 and Bax, thereby promoting granulosa cells apoptosis (Toda et al., 2001)
Seiwerth, S., Milavi?, M., Vukojevi?, J., Gojkovi?, S., Krezi?, I., Batelja Vuleti?, L., Horvat Pavlov, K., Petrovi?, A., Sikiric, S., Vrane, H., Prtoric, A., iek, H., ?urain, T., Dobri?, I., Stareini?, M., trbe, S., Kneevi?, M., ola, M., Kokot, A., & Sever, M
The appeal adds diagnosis records, clinical notes, and a medical-necessity letter
After encouraging phase 1 evidence [73]safety, tolerability, imaging, wet biomarkers, and clinical measuresand confirmation of its safety at high doses (3000 mg/day) in PD [74], a proof-of-concept study (NCT03568968) and a dose-optimisation study (NCT05589766) of NR are currently underway
E., Shataeva, L